The steady advances in machine learning and accumulation of biomedical data have contributed to the development of numerous computational models that assess the impact of missense variants. Different methods, however, operationalize impact differently. Two common tasks in this context are the prediction of the pathogenicity of variants and the prediction of their effects on a protein's function. These are related but distinct problems, and it is unclear whether methods developed for one are optimized for the other. The Critical Assessment of Genome Interpretation (CAGI) experiment provides a means to address this question empirically. To this end, we participated in various protein-specific challenges in CAGI with two objectives in mind.
INTRODUCTION
In the era of high-throughput sequencing, computational methods that predict the impact of newly discovered variants have become integral to the studies of disease (Peterson, Doughty & Kann, 2013; Niroula & Vihinen, 2016; Rost, Radivojac & Bromberg, 2016) . Different methods, however, use different definitions of impact, depending on the established practices in the research community that their developers and users belong to. Broadly speaking, an impactful variant can be interpreted in an evolutionary sense as "deleterious," that is, affecting reproductive fitness, or in a biochemical and molecular sense, as "damaging" to a protein's function, that is, function-affecting (MacArthur et al., 2014) . Another term, "pathogenicity," has been used to describe disease-causing variants and is usually interpreted as clinically significant (Richards et al., 2015) . These terms are often used interchangeably and, consequently, predictions from one class of methods may be misused to inform decisions regarding related but different concepts.
It has been pointed out, for instance, that evolutionary conservation is not sufficient to establish pathogenicity (MacArthur et al., 2014) and that many variants that affect protein function appear to be diseaseneutral (Schaefer et al., 2012; Bromberg, Kahn, & Rost, 2013; LugoMartinez et al., 2016) .
Computational methods for variant impact prediction either rely on rules derived from expert knowledge or on data-driven machine learning algorithms (see Peterson et al. [2013] for an overview). The basic idea behind supervised machine learning methods involves "training" a computer to "learn" a mathematical function (model) that relates observable features (e.g., protein sequence) to known outcomes (e.g., protein function), in order to make predictions on a previously unseen set of observed features. Ideally, the choice of training data and features leads to the optimization of a mathematical function that captures the underlying biology. For instance, it has been observed that a predictor of protein-protein interaction (PPI) sites tends to predict hotspots (residues critical for interactions) more strongly than other interacting residues (Ofran and Rost, 2007) . However, this behavior is not guaranteed. In the context of impact prediction, there are methods, particularly for missense variants, that rely on similar training data and feature sets to predict various notions of impact. Several questions, thus, naturally arise. Do these models learn some principles that underlie what makes an amino acid substitution impactful? Are they all learning similar or different classification functions? Or how can one use available data from disparate experimental studies to improve learning of each notion of impact?
Before addressing such questions, it is important to understand these methods in the context of the aforementioned variance in terminology. Supervised or semisupervised learning methods can be divided into those that are trained on variants demonstrated to affect protein function in vitro or in vivo, for example, SNAP (Bromberg & Rost, 2007) , SNAP2 (Hecht et al., 2015) , and those that are trained directly on known pathogenic variants, for example, PhD-SNP (Capriotti et al., 2006) , MutPred (Li et al., 2009 ), PolyPhen-2 (Adzhubei et al., 2010) , FATHMM (Shihab et al., 2013) , and VEST (Carter, Douville, Stenson, Cooper, & Karchin, 2013) . This allows us to disambiguate the two different but related binary classification tasks that these methods address: the classification of amino acid substitutions as (1) protein function altering or not, and (2) pathogenic or benign. This distinction has been made previously (Schaefer et al., 2012) and has recently been reiterated (Hecht et al., 2015; Richards et al., 2015) .
Pathogenic amino acid substitutions can be understood as those that severely affect protein function (note that we do not specifically address variants that disrupt protein structure and its dynamics, but rather group those into the broader classes of function impacting, pathogenic, or other variants depending on their downstream consequences). Therefore, a predictor trained on functional variants should be able to predict pathogenic ones as those that score highly. Indeed, it has been shown that pathogenic amino acid substitutions can be predicted using functional effect predictors with reasonable accuracy (Schaefer et al., 2012; Reeb et al., 2016) . Schaefer et al., 2012 further demonstrated that SNAP's prediction scores for disease mutations tend to be higher than even those for the function-altering mutations that it was trained on and that PhD-SNP predicted nearly two-thirds of function-altering substitutions from SNAP's training set as disease-causing. However, Bromberg et al. (2013) found that SIFT and PolyPhen-2 do not capture effect severity as well as SNAP Currently, training variants for pathogenicity predictions are obtained from databases such as the Human Gene Mutation Database (HGMD) (Stenson et al., 2014) and SwissVar (Mottaz et al., 2010) , which do not necessarily annotate the lines of evidence used to establish impact and are sparse on specific experimental outcomes. This suggests that pathogenicity predictors, in particular, are exposed to a broad spectrum of functional outcomes under the umbrella of "pathogenic" and "benign." Second, there has been a growing debate over whether general-purpose pathogenicity prediction models trained on variants combined from multiple genes are more powerful than gene-specific models. Recently, a case has been made for the development of both as the performance advantages relate to the amount and composition of the training data available for each protein (Riera et al., 2016) .
Finally, in spite of substantial curation efforts, errors and biases are major issues with public databases (Schnoes et al. 2009 ). This has particularly been noted in the case of HGMD (George et al., 2008; Cassa et al., 2013) , and it is not clear whether learned models are robust to this noise in practice.
Community experiments such as the Critical Assessment of Genome Interpretation (CAGI) provide excellent opportunities to not only assess the status of the field but also address the aforementioned questions through controlled studies. To this end, we participated in multiple challenges in CAGI by primarily submitting predictions from MutPred, a random-forest-based predictor that we previously developed to classify pathogenic and benign variants (Li et al., 2009) . A distinguishing feature of MutPred is that it includes internal predictors for specific structural and functional properties such as secondary structure, intrinsic disorder, DNA-binding, phosphorylation, and others. For a given amino acid substitution, MutPred runs these predictors on the original and mutated sequence, models the putative change in the propensities for these properties, and uses them to predict pathogenicity. Sequence-and structure-based analyses have revealed that such changes in local properties account for a substantial fraction of disease-causing mutations and can classify pathogenic variants more effectively than conservation-based approaches (Li et al., 2009; Mort et al., 2010; Lugo-Martinez et al., 2016) . However, it is not clear whether such site-specific or region-specific changes in structure and function are predictive of impact beyond the protein level.
In this study, we take advantage of the numerous data sets available as part of the CAGI experiment to assess the utility of general sequence-based methods for pathogenicity prediction such as MutPred for more specific prediction tasks. In particular, we address the following questions: (1) Are pathogenicity predictors trained on mutations from multiple proteins useful for individual protein-specific prediction tasks? (2) Can predictors trained to distinguish between pathogenic and benign variants predict the outcomes of functionspecific experimental assays? (3) Are pathogenicity predictors robust to heterogeneity in evidence for pathogenicity/functionality in current training and test sets? (4) Do supervised learning approaches capture the biologically intuitive relationship between pathogenicity TA B L E 1 Summary of data sets selected for this study 
MATERIALS AND METHODS

Data sets
Over the four iterations of the CAGI experiment, several prediction challenges accompanied by data sets obtained through different types of experimental techniques have been archived on the CAGI Website (https://genomeinterpretation.org/). In this study, only those data sets containing mutations (predominantly amino acid substitutions) from a single gene or a small set of genes were selected (Table 1) . For each challenge, raw ground truth values were extracted from the official results file provided along with the data set. For four challenges, experimental results have already been published by the data providers and were obtained directly from the literature: the p16 challenge (Scaini et al., 2014) , the Na V 1.5 channel challenge (Calloe et al., 2013) , the 2010 cystathionine beta-synthase (CBS) challenge (Dimster-Denk et al., 2013) and the CHEK2 challenge (Le Calvez-Kelm et al., 2011) .
When numbering all the mutations in this work, the initiation codon was assumed to be codon 1.
Processing
For all challenges, only missense variants were extracted from the original data sets. Variants without experimental values and/or predictions (due to mismatch between reference residue in the variant and that in the reference sequence) were excluded. For challenges where experimental quantities were expressed as percentages, the values were mapped to the (0, 1) interval. In challenges where the combined effects of multiple mutations were to be predicted, the predictors were run on each mutation individually and the maximum value was chosen as the final prediction. This approach was chosen over other potential approaches in a systematic analysis on the SUMO ligase challenge and applied to the other data sets without further experimentation. The underlying assumption of this approach was that the combined effects of multiple substitutions would not exceed the effect of the most deleterious variant. Other challenge-specific aspects of data set construction are outlined below.
The MRN, RAD50, and CHEK2 challenges contained data sets derived from case-control sequencing studies. In these special cases, the ground truth for each variant was available through the numbers of case and control individuals harboring it. When counts for different subpopulations were available, they were summed together to create single pooled count sets. To establish ground truth values, the probability of pathogenicity for a variant was estimated in two ways: (1) as the fraction of its occurrence in case individuals among all individuals carrying the variant, and (2) as the same fraction when the imbalance between case and controls was accounted for. This casecontrol-balanced frequency was calculated as:
, where "carrier" indicates that the variant is carried by an individual. A frequency value of 0.5 indicates that a variant is equally likely to occur in the case and control cohorts. Any variant with a value greater than this was treated as a pathogenic variant. To assess the effect of this frequency threshold on predictor performance, it was varied between 0.1 and 0.9 in increments of 0.1, and area under the curve (AUC) values were calculated at each threshold. For the SUMO ligase challenge, experimental values could be negative and were set to zero to fall within our predictors' score distributions. Apart from evaluating predictions in terms of raw experimental values, all variants were classified into four groups, based on thresholds defined by the official CAGI assessors. If a value for a variant was <0.3, it was considered to be "deleterious". If its value was ≥0.3 and <0.7, it was treated as "unsure." If the variant had a value ≥0.7 and <1.3, it was considered to be "wild-type" and any variant with a value ≥1.3 was treated as "advantageous."
Predictors
Pathogenicity predictions were made on all missense mutations from these data sets using two different predictors. First, MutPred, an existing random forest-based method that relies on sequence, conservation, predicted structural, and functional features to make pathogenicity predictions, was used (Li et al., 2009 ). Second, a neural network ensemble using an expanded feature set was trained on a much larger and more heterogeneous data set obtained from HGMD (Stenson et al., 2014) , SwissVar (Mottaz et al., 2010) , dbSNP (Sherry et al., 2001) , and others (details of this approach will be described elsewhere). This predictor will be referred to as MutPred2 (Pejaver et al., 2017) . The predictor was run in two modes, with or without accounting for gene families in training. These features simply enumerate proteins in the human and mouse genomes at various levels of sequence identity to the protein in which the variant is observed. We informally refer to these features as "homolog counts." Both MutPred and MutPred2 require only a protein sequence and an amino acid substitution as input, and output scores between zero (benign) and one (pathogenic). For challenges where experimental assay scores were expressed as a fraction of the wild-type function, prediction scores were "inverted" by subtracting them from one. Thus, a score of zero would indicate a complete loss of function and a score of one would indicate similar function levels as the wild-type protein.
Evaluation
For prediction tasks that were treated as soft (unthresholded) classification problems, the predictors were assessed as rankers. The area under the receiver operating characteristic (ROC) curve was therefore chosen as an evaluation metric (Fawcett, 2006) . In the case of regression tasks, to measure the concordance between prediction scores and actual experimental values, one or more of the following measures was used: Pearson's correlation, Spearman's rank correlation, and the rootmean-square deviation (RMSD) (Rosner, 2010) . The choice of metric varied depending on how evaluations were undertaken by the official CAGI assessors for each challenge. Performance values for other methods were obtained from the assessors' materials on the CAGI Website. For more systematic comparisons, the reader is referred to the assessors' publications.
RESULTS
The CAGI experiment has resulted in a valuable repository of data sets associated with a variety of prediction tasks. For the purposes of this study, we concentrated on protein-specific data sets rich in amino acid substitutions. This resulted in a collection of 11 data sets covering 13 proteins, with the number of protein variants ranging from three to 5,109 (Table 1) 
Prediction of the effects of pathogenic amino acid substitutions identified through sequencing studies
In this section, we describe results for prediction challenges where the true values for impact were assigned based solely on genetic evidence with no additional biochemical or molecular experiments. For the four challenges covered here, frequency of occurrence or the mere presence of variants in patient and control cohorts largely influenced their categorization as being pathogenic.
BRCA challenge
Myriad Genetics, a molecular diagnostic company, has created the pro- variant -favor polymorphism, and (4) variant of unknown significance (VUS). The basis for these designations is proprietary but is thought to incorporate information from patient testing, population-level variant frequencies, and segregation of variants in families with disease. In the BRCA challenge, the goal was to predict the probability that Myriad
Genetics classified each of 100 BRCA variants into one of these four classes. Apart from this multiclass classification task, a more straightforward task was to predict the probability that Myriad Genetics classified a given variant as deleterious (a binary classification problem).
Since our predictors were directly amenable to this task, we concentrated on the prediction of the deleteriousness of variants, particularly missense variants. As a result, of the 19 and 42 missense variants in BRCA1 and BRCA2, respectively, only four and seven were considered for evaluation. The remaining missense variants had been classified as VUS by Myriad Genetics and any quantitative evaluation was infeasible.
The predictions for these 11 variants are summarized in Table 2 along with their class labels. In the case of BRCA1, both predictors returned perfect predictions with AUC values of one. For BRCA2, the AUC values of MutPred and MutPred2 were 0.90 and 0.67, respectively. However, when the two variants classified as "probably benign"
were excluded, both methods resulted in AUCs of one. This suggests that the difference between the methods lies in how such "probably benign" variants were ranked relative to other variants in BRCA2. In fact, the MutPred2 score distribution was such that a low score threshold was sufficient to classify variants as deleterious (Table 2) . This was probably due to the selection of the MutPred2 model that included protein-level homolog counts as features. Although this model performed better than the one without these features, it typically rescales scores based on the number of homologs that a given protein has in human and mouse. Overall, while it appears that MutPred performed better than MutPred2, the results were inconclusive, due to the small data set size, class imbalance, and the lack of additional experimental evidence for deleteriousness. We note that only MutPred predictions were included in our official submission to the challenge, and it was found to be the best-performing method by the assessors.
TA B L E 2 Predictions on missense variants classified by Myriad Genetics
BRCA1
We then performed a qualitative analysis of the scores from both predictors for the 50 variants designated as VUS. We found that
VUSs from both genes were dominated by benign predictions for both predictors (Fig. 1 ). This is in general agreement with the majority of the official CAGI submissions. However, the score distributions of MutPred and MutPred2 differed from each other significantly F I G U R E 1 Score distributions for missense variants designated as VUS by Myriad Genetics in (A) BRCA1 and (B) BRCA2. The raw prediction scores from the two methods are marked on the x-axis. The density values on the y-axis were estimated by using the default kernel smoothing function ksdensity in MATLAB. For a given prediction score, the higher the density value, the more frequently observed it is in the given data set for both BRCA1 (Kolmogorov-Smirnov P = 1.1 × 10 −3 ) and BRCA2
(Kolmogorov-Smirnov P = 9.7 × 10 −3 ). In the case of MutPred, the score distribution peaked in the interval (0.3, 0.4) for both BRCA1 and BRCA2 and was slightly bimodal for BRCA2. On the other hand, MutPred2 favored lower scores, peaking in the interval (0.1, 0.2) for both genes with a shorter right tail for BRCA2. This trend agrees with that in Table 2 . We speculate that, in addition to the homolog count features, the different score distributions for the two predictors largely arise due to an expanded feature set and the use of neural networks in MutPred2.
MRN and CHEK2 challenges
In addition to the BRCA genes, there were four other genes with only genetic evidence for pathogenicity of their variants in the CAGI experiment. These were MRE11A, NBN, RAD50, and CHEK2 and their variants were provided in three distinct challenges: the MRN challenge (for the first two genes), the RAD50 challenge, and the CHEK2
challenge. However, all of these challenges were structured similarly.
Variants in these four genes were obtained from breast cancer case and control individuals through population-level sequencing at the respective loci; for details see (Le Calvez-Kelm et al., 2011; Damiola et al., 2014) . The goal of these challenges was to predict the probability of a given variant occurring in an individual from the case group. Since the challenge focused primarily on rare variants, these probabilities (derived from frequencies) were very similar to each other and evaluating the task as a regression problem would be too stringent. Therefore, we treated this task as a binary classification problem, applied our predictors to only missense variants and evaluated them using AUC.
However, it is important to note that the definition of whether a variant was truly pathogenic or not depended on its frequency in cases and controls. Therefore, in addition to the default threshold of 0.5, we investigated the effects of varying class label thresholds on AUCs as well.
Evaluation results for all four genes are summarized in Figure 2 .
In all four cases, the MutPred2 model with homolog count features was used as it performed comparably or better than the model without these features. In the case of MRE11A, the AUC for MutPred was higher than that for MutPred2 (0.66 vs. 0.62). However, at low false positive rate (fpr) values, MutPred2 identified more true positives than MutPred ( Fig. 2A) . As the cutoff for pathogenicity was increased, both predictors improved performance and converged to similar AUC values (Fig. 2B ). For RAD50, although MutPred had a smaller AUC value than MutPred2 (0.63 vs. 0.68), the performances were very similar, differing only at high fpr values (Fig. 2C) . Again, both predictors showed similar performance at higher frequency thresholds, with MutPred being more stable (Fig. 2D) . NBN deviated from the other members of the MRN complex in that both predictors performed worse than random at the default frequency threshold, with MutPred2 doing slightly better (Fig. 2E) . Interestingly, this performance was recovered for both predictors when the threshold was decreased, that is, unlike the previous case, more relaxed thresholds (0.2, 0.3) yielded better performances, with MutPred reaching AUC values up to 0.7 (Fig. 2F) . Finally, in Figures 2G and H, we describe the results for CHEK2. Although the AUC for MutPred was higher than that for MutPred2 (0.64 vs.
0.61), their true-positive rates in the (0, 0.1) fpr interval were comparable. Furthermore, AUC values for both predictors at lower frequency thresholds were equal, with MutPred's performance improving at more stringent thresholds. These results held even when the true pathogenicity labels were assigned based on case-control-balanced frequencies (Supp. Tables S1-S4).
We note that the official CAGI assessors used measures other than AUC. Although our AUC values for these four genes were modest at best, the official assessment concluded that MutPred was the best-performing method for the RAD50 challenge (MutPred2 had not been developed at the time). To the best of our knowledge, all submitted predictors performed poorly on MRE11A and NBN and our predictors were among the better performing ones. Although some of the variants in these data sets were included in our predictors' training sets (more so for MutPred2; data not shown), the comparable performances of both predictors indicates no significant advantage to either of our methods. This suggests that either variants from these genes are difficult to predict on with current approaches or that the frequency-based annotations of pathogenicity are generally unreliable.
Prediction of the effects of amino acid substitutions on protein activity and function
In these challenges, the ground truth values were established through in vitro biochemical assays. Typically, these experiments first involved expression of proteins of interest in cells followed by their extraction from cell lysates and purification. Then, specific functions such as enzyme activity or binding affinity were assayed against known substrates or analogs. Although several mutations, and almost all of the proteins (NAGLU, NPM-ALK, and PKLR), covered in this section are medically important, the prediction tasks here focused mostly on the specific functional consequences of these mutations, without regard to cellular or organismal phenotype.
NAGLU challenge
The most recent challenge in this category was the prediction of the effect of naturally occurring missense mutations on the enzymatic activity of NAGLU, a lysosomal glycohydrolyase. Deficiency of NAGLU and/or its mutations cause Mucopolysaccharidosis IIIB or Sanfillipo B disease. The data set consisted of 165 missense mutations extracted from the Exome Aggregation Consortium (ExAC) data resource (Lek et al., 2016) . The effects of these mutations on NAGLU's hydrolysis activity were assayed and quantified relative to the wild type to establish ground truth values. An activity value of zero indicated complete abolition of activity, a value of one indicated wild-type levels of activity and any value greater than one indicated activity greater than the wildtype value. We evaluated our predictions in two ways. First, we treated every mutation with activity levels > 0.1 (Wyatt T. Clark, personal communication) as wild-type-like and evaluated the task as a binary classification problem. Second, we treated the task as a regression We found that the inclusion of homolog count features had little impact on the predictive performance of MutPred2 and, therefore, considered the model without these features. Irrespective of whether mutations with activity levels above 1 were included or not, the AUCs of MutPred and MutPred2 were 0.78 and 0.85, respectively (Fig. 3A) .
This was the case even when considering Pearson correlation coefficients. MutPred was less correlated with activity values (r = 0.54; P = 3.4 × 10 −13 ; t-test) than MutPred2 was (r = 0.62; P = 1.1 × 10 −17 ; ttest) when mutations with activity levels above 1 were excluded. When these mutations were included, the corresponding correlation coefficients were 0.54 (P = 1.6 × 10 −13 ; t-test) and 0.61 (P = 6.7 × 10 −18 ; t-test). Overall, MutPred2 outperformed MutPred and was, in fact, judged to be the best-performing method among all submissions for this challenge.
Interestingly, as in the case of the BRCA VUS, the distributions of scores output by MutPred and MutPred2 were very different. Unlike
MutPred2, MutPred predicted no activity values to be greater than 0.7 and the spread of scores appeared more "compressed" (Fig. 3B and C). One possible explanation for this is that MutPred2 was trained 
NPM-ALK challenge
NPM-ALK is a protein formed through the fusion of NPM1 and anaplastic lymphoma kinase (ALK). This fusion results in the ALK tyrosine kinase being constitutively activated and contributing to cancer.
NPM-ALK is dependent on the molecular chaperone Hsp90 for its stability and activity. In this challenge, the goal was to predict the effects of 23 mutations (19 missense) on two distinct and separately assayed functions of NPM-ALK relative to the wild-type protein, kinase activity, and Hsp90-binding affinity. In both cases, the experimental values were set to zero if the given function was completely lost, 0.5 if the activity or binding was less than that of the wild-type protein, one if the function was at wild-type levels, and two if the function was above wild-type levels. We ran and evaluated our predictors solely for this study and did not officially participate in this challenge. We note that MutPred2 uses predicted losses and gains of specific protein properties (as a consequence of mutation) such as catalytic activity, stability, and PPIs as features. Therefore, in addition to the general scores output by our predictors, we evaluated scores from these individual predictors as well.
We note that all mutations in the data set were mappable to the ALK protein and predictions could be made on either NPM-ALK or ALK. We chose ALK, as our performance on this sequence was better overall. For the first task, MutPred correlated better with kinase activities than MutPred2 when all mutations were considered. However, the trend reversed when only those mutations with activity values ≤1 were considered (Fig. 4A) . To put these results in context, r of the best-performing method at CAGI was 0.88. However, we note that these methods were developed and/or customized for this challenge. When the assessors used general pathogenicity predictors such as SIFT (Ng & Henikoff, 2001 ), PolyPhen-2 (Adzhubei et al., 2010) , and PROVEAN (Choi et al., 2012) , the best-performing method (PolyPhen-2) had a coefficient of 0.47. Furthermore, when
MutPred2's internal catalytic site predictors were considered, correlation levels increased to those comparable to the top CAGI submissions.
F I G U R E 4
Evaluation of the performance of our predictors on the NPM-ALK challenge. Spearman correlation coefficients for (A) the kinase activity prediction task and (B) the Hsp90-binding affinity task. "Wild" scores were obtained by running the in-house predictor for the given property on wild-type sequence. "Mutant" scores were obtained similarly on the mutated sequence. Property scores combined "wild" and "mutant" values as described in Pejaver et al. (2017) . A "*" adjacent to a bar indicates a statistically significant correlation (with Bonferroni correction).
Next, we considered the Hsp90-binding affinity predictions. This task turned out to be much harder with the only positive correlation value arising from predictions made by MutPred when affinityincreasing mutations were excluded (Fig. 4B) . Interestingly, the PPI property predictors resulted in positive correlations in all but one case.
However, none of these were statistically significant and were only better than MutPred when all mutations were considered. In the official assessment, all predictions were virtually random with the top r being 0.05, much below those of a majority of our approaches. These trends held even when considering Pearson's correlation coefficients, except in the case of PPI mutant scores; a positive correlation was observed when affinity-increasing mutations were excluded, suggesting a strong linear relationship between the predicted and true values (Supp. Fig. S1 ).
Pyruvate kinase challenge
Pyruvate kinase is an enzyme that catalyzes the last step in glycolysis and is regulated by two allosteric effectors, alanine and fructose 1,6
bisphosphate (Fru-1,6-BP). Of the four isoforms expressed from the pklr gene in mammals, the one specific to the liver, L-PYK, is of par- 0.74 and 0.59, respectively) for the two data sets.
Next, we evaluated the ability of our methods to predict effects on allosteric regulation by alanine and Fru-1,6-BP. These were measured in both experiments for alanine and only in the second experiment for
Fru-1,6-BP. Unlike other challenges, all mutations were retained here because none of these values exceeded one for alanine and all but one were below one for Fru-1,6-BP. We found that MutPred2 was the only approach with positive correlations in all three cases (Fig. 5C ). 
Prediction of the effects of amino acid substitutions measured at the cellular level
In order to establish the causal roles of variants in disease, it is often insufficient to demonstrate their effects on an isolated protein's function. A common approach is to measure the effects of such mutations on measurable cellular parameters such as growth rate, detection of signals in or outside the cell, protein turnover, among others. The CAGI experiment included four such challenges: the SUMO ligase challenge, the p16 challenge, the SCN5A challenge, and the CBS challenge (with two different data sets). Each of these used different experimental endpoints to assign variant impact and are described in this section along with the evaluation of our predictions. It is important to note that these experiments are often carried out on cell lines and may or may not reflect actual phenotypes at the organism level.
SUMO ligase challenge
This challenge constitutes the largest data set of mutations in our collection and was generated through a high-throughput yeast com- Finally, the third subset consisted of 4,427 combinations of two or more amino acid substitutions occurring together. The predicted values were expected to be between zero (no growth) and one (wild-type growth), or greater than one (more growth than wild type). We note that for this challenge, a score distribution was provided to calibrate raw prediction scores. While our official submissions included this calibration step, in this study, we aimed to investigate the direct applicability of our methods and, therefore, used the raw scores. Calibration only provided modest improvements over the results from the raw scores.
Based on thresholds established by the CAGI assessors, we divided the data set into two classes (deleterious or wild type) and obtained ROC curves for both predictors (Fig. 6) . In subsets 1 and 2, we found that both predictors had comparable performances with slight advantages belonging to MutPred2 in subset 1 and MutPred in subset 2. This trend remained even when the "unsure" variants were included in the "deleterious" class (Table 3 ). However, both predictors' performance improved on subset 1 and dropped on subset 2 when the "unsure" variants were reassigned. In this case, the trend for subset 1 agreed with the trend for subset 3 and we concluded that subset 2 deviated from the other subsets due to the noise introduced by a larger fraction of low-confidence growth values. As can be seen in Table 3 , Spearman correlation coefficients between predicted and experimental growth rates followed a similar pattern as the AUC values with modest differences between the two predictors. We note that the exclusion of "unsure"
variants made both subsets easier to predict on and that the performance improved for both predictors (data not shown).
F I G U R E 6
Performance of both predictors on the three subsets of the SUMO ligase variants. All "unsure" variants were included in the "wildtype" class and all "advantageous" variants were excluded from the analyses. A: ROC curve for the set of variants with high-confidence growth rate values (subset 1). B: ROC curve for the set of variants with low-confidence growth rate values (subset 2). C: ROC curve for the set containing combinations of two or more amino acid substitutions occurring together (subset 3) All correlations are significant at a P-value threshold of 0.05. a Official submission to CAGI.
TA B L E 3 Performance measures for the prediction of the deleteriousness of amino acid substitutions in SUMO ligase
Subset 3 was a harder task for both predictors as neither of them were designed to predict the combined effects of multiple substitutions. We therefore decided to run the predictors on individual mutations and perform postprocessing to assign a single value to each multimutant protein variant. Table 3 shows the three different postprocessing methods that we explored, and, clearly, taking the maximum predicted value among individual predictions for a variant worked the best for MutPred2 and the average predicted value worked slightly better for MutPred. Both predictors showed modest correlations with experimental values. We note that the official assessors for this particular challenge used multiple sophisticated metrics to identify the best method. Although our methods were not the best performing, their performances were very similar to the state-of-the-art, suggesting that UBE2I is a hard target to predict on with current methods.
p16 challenge
The CDKN2A gene codes for two proteins through alternate splicing of its first exons, both of which have tumor-suppressor functions. Among these, the p16 isoform inhibits cyclin-dependent kinase (CDK4/6) and, thus, promotes cell cycle arrest and affects cell proliferation. Mutations that affect the inhibitory function of p16 cause cells to grow rapidly and contribute to malignant melanoma. The p16 challenge involved the prediction of cell proliferation rates as a consequence of 10 different mutations at four positions in p16. These rates were set by TA B L E 4 Predictions of the effects of 10 mutations in p16 on cell proliferation rates the data providers to be 0.5 for wild-type cells (negative controls) and one for tumor-like cells (positive controls). Since a mutation resulting in a growth rate closer to 0.5 could be interpreted as being "benign" and that with a rate closer to one could be interpreted as "pathogenic," we directly applied our predictors to this data set. Our predictions were evaluated in two ways. First, we treated every mutation with growth rate above 0.75 as tumor-like and evaluated the task as a binary classification problem. Second, we treated the task as a regression problem and calculated the RMSD to determine how close our predicted proliferation rates were to actual experimental values.
The results for the p16 data set are summarized in Table 4 . When evaluated as a classification task, both models in MutPred2 (with or without homolog counts) outperformed MutPred (AUC values of 0.80 and 0.84, respectively, vs. 0.68). This is the case even for RMSD values except that the MutPred2 model with homolog counts had the lowest RMSD (0.1397), followed by the other MutPred2 model (0.1506) and MutPred (0.2061). As suggested before, the better performance of the homolog count model can be explained by the fact that the inclusion of these features rescales scores, which better mimic actual proliferation rate distributions. Since we did not participate in this challenge,
we directly compared our performance values with other methods that were officially assessed. MutPred2 had an AUC value comparable to the top-performing methods and the second-best RMSD value among all methods submitted.
Na V 1.5 challenge
This challenge involves the smallest data set among all the challenges described in this study. SCN5A encodes the Na V 1.5 integral membrane protein, primarily found in cardiac muscle cells and is responsible for mediating the fast influx of Na + ions across the cell membrane. This influx, in turn, results in the fast depolarization of the cardiac action potential. Thus, this protein plays an important role in impulse propagation through the heart. Although mutations in SCN5A
have been associated with multiple heart diseases, this challenge concentrates on those that have been linked to Brugada syndrome (Calloe et al., 2013) . The data set contains three missense mutations obtained by sequencing two independent families and screening the resulting mutations against a control group. The effects of these mutations on current flow were measured by patch clamp experiments and expressed as the fraction of the reduction in current density due to the mutation, when compared with the wild-type protein. The goal of this challenge was to predict these current density fraction values. We did not officially participate in this challenge and ran our predictors on this data set solely for this study. Table 5 shows the prediction scores for the three mutations along with actual current density values obtained from Calloe et al. (2013) .
Although the data set was too small to assign statistical significance to our results, we found the Spearman correlation coefficients to be one for both prediction methods. The Pearson correlation coefficients were 0.83 and 0.90 for MutPred and MutPred2, respectively. This suggests that while scores from both predictors were monotonically related to current density fractions, MutPred2 scores were linearly related to these fractions and could directly be applied to this prediction task. Interestingly, although both function-altering mutations were present in MutPred2's training set as pathogenic, it was able to reasonably predict actual outcomes from the patch clamp experiments.
CBS challenge
One of the earliest challenges included in the CAGI experiment was the prediction of the effects of mutations in CBS on its function. CBS were carried out with high (400 ng/ml) and low (2 ng/ml) cofactor concentrations. The goal was to predict cell growth rates expressed as a fraction relative to the wild type with the same amount of pyridoxine supplementation, where zero indicates complete loss of function and one indicates wild-type levels of function. Since the data sets also provided explicit binary information on whether a variant was nonfunctional or not, we directly ran our predictors on these data sets and evaluated them as both classification and regression problems.
We found that MutPred2 (without homolog counts) had greater AUC values than MutPred in both data sets ( Fig. 7A and B) . However, in the 2011 data set, MutPred was more sensitive in the low fpr interval; 79 of the 84 mutations in the 2011 data set were present in MutPred's training set (78 pathogenic and one benign) and 81 were present in MutPred2's training set (79 pathogenic and two benign). Of these pathogenic mutations, only p.Asn228Lys occurred in the 2010 data set. Since our predictors were trained in a binary classification scenario similar to this challenge (albeit with different class definitions), we calculated Spearman's correlation coefficients as an additional measure of performance. When mutations with relative growth rates above one were excluded, MutPred2's scores correlated better with experimental values than MutPred's for the 2010 data set but the converse was true for the 2011 data set ( Fig. 7C and D) . Predictions from both methods correlated better with the rates at high pyridoxine concentrations in the 2010 set but were similar in both experimental conditions in the 2011 data set. This was perhaps due to the lack of null mutant growth rates for the low concentration experiment in the 2010 data set ( Fig. 7C; second column) . When the full set of mutations was considered for each data set, MutPred2 outperformed
MutPred on all data sets in all experimental conditions (Supp. Table S5 ),
suggesting that its scores scaled better even when mutations outside its prediction range were included. We note that neither of these meth- 
DISCUSSION
In this study, we applied two pathogenicity predictors, MutPred Both methods were trained on large sets consisting of amino acid substitutions from thousands of genes and were not specifically tuned for any particular gene or task at hand. They performed comparably or better than the top-performing methods identified by the independent assessors. In some cases, these methods only utilized information specific to the given gene, implicitly suggesting that generic models trained on larger data sets benefit from information learned from other genes. This is in general agreement with a recent systematic study that concluded that the best-performing generic models frequently outperform gene-specific ones (Riera et al., 2016) . In addition, our results provide insights on the transferability of pathogenicity predictors to the prediction of functional effects of missense mutations, the robustness of these predictors to heterogeneity in evidence types in current test sets, and the interpretability of these models in a biological context, that is, the relationship between the problem of predicting pathogenic variants and that of predicting function-altering variants.
MutPred and MutPred2 models generalize to different prediction tasks
It has been previously argued that functional effect predictors can predict disease-related mutations with reasonable accuracy and that prediction scores correlate with effect severity (Schaefer et al., 2012 
Predictor score distributions matter
When considering metrics that measure the concordance between experimental and predicted values, MutPred2 performed better than MutPred, for example, the NAGLU, pyruvate kinase, p16, and the CBS challenges. A major factor contributing to this are the differences between the score distributions of the two methods. MutPred2 had a spikier score distribution on the BRCA VUS data set and was more spread out in the NAGLU challenge. The learning algorithm in MutPred2 is a neural network, which can approximate any discriminant function (Cybenko, 1989) as well as posterior probabilities of the underlying distribution of inputs and outputs (Rojas, 1996) . Score distributions of predictors are often viewed and optimized in terms of the separation between different classes. However, our results support the attempts to approximate posterior distributions as closely as possible (Rost, Radivojac & Bromberg, 2016) . While random forests (MutPred) performed comparably or even better than MutPred2 on classification tasks, they were frequently outperformed on the prediction of functional effect severity. We speculate that this may be due to the differences between the individual components of the two ensemble models: neural networks and classification trees. Although both neural network ensembles and random forests involve averaging the outputs of these individual predictors, the smoother approximation of posterior distributions by the neural networks seems to better capture the intermediate levels of functional effect severity. Our arguments are further supported by the fact that SNAP (which has been demonstrated to correlate with the magnitude of functional effects) also relies on neural networks. 
The
Predictors trained on variants from multiple genes in HGMD are robust
Public databases provide valuable data for systematic hypotheses testing and the development of predictive models. However, issues of uncertainty (overlap between class-conditional distributions in a given feature space), sample selection bias, and noise will always have to be overcome either through best practices in data processing or by the models themselves (Rost, Radivojac & Bromberg, 2016) . We found that supervised learning methods that rely on large resources for training were actually useful on tasks specific to individual proteins. Our predictors were competitive with or in some cases better than methods customized for the given protein and/or task, for example, the p16, CBS, and NPM-ALK challenges.
Interestingly, all pathogenic mutations in the MutPred training set and a substantial fraction in the MutPred2 training set derive from HGMD. From our experience going beyond this specific study, both
MutPred models heavily benefited from the use of this database.
Results from recent large-scale studies on the development of metapredictors for pathogenicity prediction support this view; predictors trained on HGMD mutations tended to perform better than other methods (Dong et al., 2015; Ioannidis et al., 2016) . This can be explained by the fact that the specialization of HGMD and its expert curators for the task of collecting and storing disease variants reduces noise, especially when the evidence for pathogenicity is variable and/or sparse.
Limitations and future work
Our work is not without limitations and we discuss them here. First, unlike in many previous studies (Bromberg et al., 2013; Schaefer et al., 2012) , the CAGI data sets covered a dozen or so proteins with significant variability in data set sizes. While our study serves as a proofof-concept for the direct applicability of our pathogenicity predictors to functional effect prediction tasks, more systematic analyses on larger data sets will be needed to fully disentangle the relationship between the two prediction problems. Second, the CAGI data sets likely contained some biases. Amino acid substitutions predominantly came from proteins that were of medical interest. Moreover, several data sets were obtained from ongoing studies with different objectives.
For example, in the 2010 CBS data set, nearly half of all mutations were selected for their mild to severe impact on protein stability (DimsterDenk et al., 2013) , as predicted by Rosetta (Kellogg et al., 2011) . Third, as of now, our methods do not account for activating mutations and this not only introduces complications for evaluation (see below) but also overestimates the direct applicability of our methods. However, since the overall ranking of amino acid substitutions were often consistent with real values, our methods would still be effective in the prioritization of interesting variants. Assigning directionality to predicted functional effects is a potential avenue for future research that should rely on predictions of specific functional activities (Lugo-Martinez et al., 2016) . Finally, while our choice of evaluation criteria for a given task was influenced by the respective CAGI assessors, our analyses were not as comprehensive. Moreover, our data handling and preprocessing protocols deviated from theirs, for example, exclusion of frameshifting indels and nonsense mutations. As a result, in some cases, our performance values did not agree with CAGI assessments. For instance, in our hands, we found the AUC values for subset 1 of the SUMO ligase challenge ranged between 0.65 and 0.71 (with varying data selection criteria), but in the official assessments our methods performed consistently around 0.75. Therefore, any direct comparisons between actual performance evaluations must be interpreted cautiously. However, our general conclusions still hold as the overall trends remained the same, for example, in the SUMO ligase challenge MutPred and
MutPred2 did cluster together with other methods, in terms of performance.
Final remarks
The CAGI experiment has enabled us to assess the utility of general machine learning models for multiple function-specific tasks and draw meaningful conclusions both on a case-by-case basis and on the aggregate. Although our results may not generalize to other predictive methods, they provide empirical support that models trained on pathogenic variants with the incorporation of local structural and functional features, transfer well to the related problem of functional effect prediction. Disambiguating specific functional effects from pathogenicity, and understanding their mutual relationship, may be of interest in the future iterations of CAGI.
